Literature DB >> 30013663

Effect of Period 2 on the proliferation, apoptosis and migration of osteosarcoma cells, and the corresponding mechanisms.

Tao Qin1, Xiao-Ting Lu2, Yong-Gang Li1, Yan Liu2, Wenjiang Yan2, Na Li2, Yuan-Yuan Sun2.   

Abstract

Period 2 (per2) is a core circadian clock gene. Dysregulation of the per2 gene has been identified in a number of types of human cancer and may be associated with a poor prognosis. To confirm the influence of per2 gene on MNNG/HOS human osteosarcoma cells, small interfering (si)RNA against per2 or plasmids containing per2 were transfected into MNNG/HOS cells, and the proliferation, apoptosis and migration were observed. The present study demonstrated that per2 knockdown significantly enhanced MNNG/HOS cell proliferation and migration and protected MNNG/HOS cells from apoptosis. Per2 overexpression inhibited MNNG/HOS cell proliferation and migration and promoted apoptosis. Furthermore, the protein expression of phosphorylated (p)-protein kinase B (Akt) and Bcl-2 were inhibited in per2-overexpressing cells, while the expression of p27, p21 and cleaved caspase-3 was promoted. In contrast, the expression of p-Akt and Bcl-2 was promoted in per2-knockdown cells, and p27, p21 and cleaved caspase-3 were decreased. This initial study may provide an alternative therapeutic strategy for the treatment of osteosarcoma.

Entities:  

Keywords:  apoptosis; human osteosarcoma cells; migration; period 2 gene; proliferation

Year:  2018        PMID: 30013663      PMCID: PMC6036572          DOI: 10.3892/ol.2018.8952

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  38 in total

Review 1.  Detection of lymph node metastases in esophageal cancer.

Authors:  George Sgourakis; Ines Gockel; Orestis Lyros; Torsten Hansen; Peter Mildenberger; Hauke Lang
Journal:  Expert Rev Anticancer Ther       Date:  2011-04       Impact factor: 4.512

2.  Activity, sleep and ambient light have a different impact on circadian blood pressure, heart rate and body temperature rhythms.

Authors:  D G Gubin; D Weinert; S V Rybina; L A Danilova; S V Solovieva; A M Durov; N Y Prokopiev; P A Ushakov
Journal:  Chronobiol Int       Date:  2017-02-16       Impact factor: 2.877

3.  Development of sleep/wake, activity and temperature rhythms in newborns maintained in a neonatal intensive care unit and the impact of feeding schedules.

Authors:  Clarissa Bueno; Luiz Menna-Barreto
Journal:  Infant Behav Dev       Date:  2016-06-01

4.  Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.

Authors:  Bo Chen; Yaoxi Tan; Yan Liang; Yan Li; Lei Chen; Shuangshuang Wu; Wei Xu; Yan Wang; Weihong Zhao; Jianqing Wu
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

Review 5.  The cell cycle and cancer.

Authors:  Gareth H Williams; Kai Stoeber
Journal:  J Pathol       Date:  2011-10-28       Impact factor: 7.996

Review 6.  Circadian molecular clocks and cancer.

Authors:  Fergal C Kelleher; Aparna Rao; Anne Maguire
Journal:  Cancer Lett       Date:  2013-10-04       Impact factor: 8.679

7.  Mammalian PER2 regulates AKT activation and DNA damage response.

Authors:  Xiaoming Yang; Xuezhong He; Zhengguan Yang; Esmaiel Jabbari
Journal:  Biochem Cell Biol       Date:  2012-08-21       Impact factor: 3.626

8.  Osteosarcoma of medial cuniform bone.

Authors:  Daniel Admassi
Journal:  Ethiop Med J       Date:  2009-10

Review 9.  New molecular insights into osteosarcoma targeted therapy.

Authors:  Jilong Yang; Wei Zhang
Journal:  Curr Opin Oncol       Date:  2013-07       Impact factor: 3.645

10.  Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.

Authors:  Hans Gelderblom; Rachel C Jinks; Matthew Sydes; Vivien H C Bramwell; Martine van Glabbeke; Robert J Grimer; Pancras C W Hogendoorn; Anne McTiernan; Ian J Lewis; Marianne A Nooij; Antonie H M Taminiau; Jeremy Whelan
Journal:  Eur J Cancer       Date:  2011-01-06       Impact factor: 9.162

View more
  8 in total

1.  Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer.

Authors:  Zhaoxia Wang; Fengyan Li; Meiyan Wei; Sanyuan Zhang; Tong Wang
Journal:  Cancer Manag Res       Date:  2020-11-19       Impact factor: 3.989

Review 2.  Metabolic rivalry: circadian homeostasis and tumorigenesis.

Authors:  Kenichiro Kinouchi; Paolo Sassone-Corsi
Journal:  Nat Rev Cancer       Date:  2020-09-07       Impact factor: 60.716

3.  Per2 attenuates LPS-induced chondrocyte injury through the PTEN/PI3K/Akt signalling pathway.

Authors:  Yu Zhao; Ding Ma; Bingchen Dong; Ming Li
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

4.  BMAL1 Modulates Epidermal Healing in a Process Involving the Antioxidative Defense Mechanism.

Authors:  Ericka J D Silveira; Carlos H V Nascimento Filho; Veronica Q Yujra; Liana P Webber; Rogerio M Castilho; Cristiane H Squarize
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

5.  Overexpression of FGF2 delays the progression of osteonecrosis of the femoral head activating the PI3K/Akt signaling pathway.

Authors:  Pei Lu; Yi-Min Shen; Ting Hua; Ting Pan; Gang Chen; Teng Dai; Ke-Qin Shi
Journal:  J Orthop Surg Res       Date:  2021-10-18       Impact factor: 2.359

6.  REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice.

Authors:  Ruyue Shao; Yongqiang Yang; Kerui Fan; Xicheng Wu; Rong Jiang; Li Tang; Longjiang Li; Yi Shen; Gang Liu; Li Zhang
Journal:  Int J Med Sci       Date:  2021-10-25       Impact factor: 3.738

7.  Period 2 Suppresses the Malignant Cellular Behaviors of Colorectal Cancer Through the Epithelial-Mesenchymal Transformation Process.

Authors:  Yubo Xiong; Yifan Zhuang; Mengya Zhong; Wenjuan Qin; Boyi Huang; Jiabao Zhao; Zhi Gao; Jingsong Ma; Zhengxin Wu; Xuehui Hong; Zhicao Yue; Haijie Lu
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

Review 8.  Circadian Rhythms Within the Female HPG Axis: From Physiology to Etiology.

Authors:  Shuyi Shao; Huanqiang Zhao; Zhiying Lu; Xiaohong Lei; Ying Zhang
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.